Selected Past Programs
HomeSelected Past Programs
High Impact Collaboration — Developing Next-Generation Inhibitors to a Key Cancer Pathway
February 11, 2021 AFCR News, Selected Past Programs
THE CHALLENGE
—Tackling the Pre-Clinical Experiments to Overcome Drug Resistance
Many patients with melanoma, papillary thyroid tumors, serous ovarian tumors, and colorectal tumors, for example, have DNA mutations that hyperactivate the major cell growth and survival pathway Ras/Raf/MEK/ERK, causing abnormal growth and cancer.
Unfortunately, patients…
Developing appropriate models for diseases such as cancer and Alzheimer’s disease is critical for dissecting their disease…
Esophageal cancer (EC) is one of the most deadly cancers worldwide, with five –year survival rates of only around 10%…
Ending Drug Resistance to Major Cancer Pathway
August 24, 2018 Basic Research, Innovative Therapies and Treatments, Selected Past Programs
The pathway, Ras/Raf/MEK/ERK, is a cascade of proteins that turn on gene regulators, playing a central role…
Understanding the risk of breast cancer in the Chinese population is very important due to the exponential increase in incidence…
Cell Polarity Proteins in Epithelial Cancers
August 24, 2018 Basic Research, Innovative Therapies and Treatments, Selected Past Programs
More than 80% of tumors originate in epithelial cells, the most common type of cells in the human body. They are found in a wide array of organs, forming the linings and surfaces…
An Innovative Treatment Initiative for Liver Cancer
August 20, 2018 Basic Research, Innovative Therapies and Treatments, Selected Past Programs
Hepatocellular carcinoma (HCC), the most typical form of liver cancer, is the second leading cause of cancer-related fatalities in Asia…
Improving the Treatment of Ovarian Cancer with Powerful microRNAs that Overcome the Resistance of Chemotherapy
April 8, 2018 Basic Research, Innovative Therapies and Treatments, Selected Past Programs
Improving the Treatment of Ovarian Cancer with Powerful microRNAs that Overcome the Resistance of Chemotherapy
Personalized Medicine For Non-Small Cell Lung Cancer Patients
April 8, 2018 Basic Research, Innovative Therapies and Treatments, Selected Past Programs
In China, there are nearly 4.5 million cancer patients and lung cancer is the most common type
Research for Developing New Markers and Targets in Colorectal Cancer: A Novel Tumor Suppressor Gene in Colorectal Cancer
April 8, 2018 Basic Research, Innovative Therapies and Treatments, Selected Past Programs
Research for Developing New Markers and Targets in Colorectal Cancer: A Novel Tumor Suppressor Gene in Colorectal Cancer
Identifying Biomarkers of Esophageal Cancer: Developing a Screening Test for Early Detection To Improve Survival
Gastric cancer is the fourth most common cancer and the second leading cause of cancer death worldwide.
Integrating international resources to promote collaboration and accelerate cancer research